These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
587 related articles for article (PubMed ID: 26056033)
1. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Burnstock G Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033 [TBL] [Abstract][Full Text] [Related]
2. Medicinal chemistry of adenosine, P2Y and P2X receptors. Jacobson KA; Müller CE Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393 [TBL] [Abstract][Full Text] [Related]
6. Purinergic Signalling and Neurological Diseases: An Update. Burnstock G CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510 [TBL] [Abstract][Full Text] [Related]
7. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17. Fumagalli M; Lecca D; Abbracchio MP Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964 [TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of purinergic signalling. Burnstock G Biochem Pharmacol; 2018 May; 151():157-165. PubMed ID: 28735873 [TBL] [Abstract][Full Text] [Related]
9. Purinergic signaling in Alzheimer's disease. Erb L; Woods LT; Khalafalla MG; Weisman GA Brain Res Bull; 2019 Sep; 151():25-37. PubMed ID: 30472151 [TBL] [Abstract][Full Text] [Related]
10. Introduction to purinergic signalling in the brain. Burnstock G Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061 [TBL] [Abstract][Full Text] [Related]